Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods and compositions for treating cartilage and disc tissue lesions

A technology of intervertebral discs and compositions, applied in the direction of bone/connective tissue cells, drug combinations, bone diseases, etc., can solve the problems of non-existing reversal or repair

Active Publication Date: 2021-01-05
MCGILL UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are currently no therapies to reverse or repair cartilage degradation in OA patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for treating cartilage and disc tissue lesions
  • Methods and compositions for treating cartilage and disc tissue lesions
  • Methods and compositions for treating cartilage and disc tissue lesions

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0237]Currently, no treatment exists to prevent, stop or even delay back pain arising from disc degeneration. Previous studies have shown that linked N can act as a growth factor and stimulate proteoglycan and collagen synthesis in IVD. However, the sequences in junction N involved in regulating cellular activity are not well understood. To determine whether disc cells can proteolytically process Junction N, human disc cells were exposed to native Junction N over a 48-hour period, and as described further below, mass spectrometry analysis revealed that peptides spanning residues 1 to 8 were significantly different in AF cells than in AF cells. generated in the presence of non-NP cells. Linking N1-8 significantly induced proteoglycan production in the presence of IL-1βNP and AF cells, confirming that the biological effect is maintained in the first 8 amino acids of this peptide and indicating that this effect persists in an inflammatory environment.

[0238] Distinct effects ...

example 2

[0282] As previously demonstrated, connexin N is released from connexin by MMP cleavage. It is produced in both joints and intervertebral discs and promotes aggrecan / collagen synthesis by intervertebral disc (NP and AF) and articular cartilage (chondrocyte) cells.

[0283] Junctional N stimulation of human intervertebral discs in organ culture has been reported to increase proteoglycan synthesis 1.15 to greater than 7-fold compared to discs injected with medium alone. Proteoglycan synthesis was detectable 9 days after ligated N stimulation.

[0284] In a rabbit model of intervertebral disc degeneration, 2 weeks after L2 / 3 circular puncture, connexin injection at a concentration of 100 μg of connexin in 10 μl of saline significantly increased IVD disc height at 14 weeks after connexininfection. Aggrecan mRNA was significantly increased in AF and NP cells, especially in AF cells. Likewise, MMP-3 and ADAMTS-4 protease expression was significantly reduced. demonstrated that the...

example 3

[0289] Methodology:

[0290] Osteoarthritic (OA) cartilage was obtained from four donors with informed consent undergoing total knee arthroplasty, and OA cartilage-bone explants and OA chondrocytes were prepared from each donor. Normal human chondrocytes (PromoCell, Heidelberg, Germany) and bovine articular cartilage (12 months) were used as controls.

[0291] Explant preparation and handling

[0292] about 1cm 2 The cartilage explants were prepared from the same donor and included cartilage with cortical bone. Explants were cultured in DMEM supplemented with 10% heat-inactivated FBS. After 7 days under standard culture conditions, the explants were exposed to: IL-1β (5 ng / ml), linked N (1 μg / ml) and co-exposed to IL1β + linked N for 21 days with media changes every three days .

[0293] Tissue Processing and Analysis

[0294] A 3 mm diameter plug of cartilage was isolated from a different region of each explant. Expression of Col II, Agg, Col X and MMP-13 was assessed ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present invention provides an isolated polypeptide comprising a peptide selected from the group consisting of: i) DHX, as well as recombinant cells and uses thereof 1 SDNYT, where X 1 is L or H (SEQ ID NO: 1); ii) a conservative variant of i); iii) a fragment of i) or ii); wherein the conservative variant and / or fragment retains biological activity, and the peptide is 15 or fewer amino acids.

Description

[0001] Cross references to related applications [0002] This application is a Patent Cooperation Treaty application based on 35 U.S.C. §119 requirements of U.S. Provisional Patent Application No. 61 / 870,394 filed August 27, 2013, and U.S. Provisional Patent Application No. 61 / 975,329, said U.S. Provisional Patent Application is incorporated herein by reference in its entirety. technical field [0003] The present disclosure relates to methods and compositions for treating cartilage and disc disorders, and in particular to methods and compositions using Link N (Link N) segments for treating cartilage and disc disorders, such as arthritis and disc degeneration. Background technique [0004] Intervertebral discs (IVDs) connect adjacent vertebrae within the spine. They consist of a peripheral annulus fibrosus (AF) and a central nucleus pulposus (NP). AF is a fibrous tissue with concentric sheets rich in collagen fibers (1). NPs have a more amorphous consistency, containing ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06C07K7/08C12N15/11C12N5/077C12N5/10A61K35/32A61K38/08A61K38/10A61K47/36A61P19/00A61P19/02A61P29/00
CPCA61K35/32C07K7/08A61K38/00C07K7/06A61P19/00A61P19/02A61P19/08A61P29/00A61K35/28
Inventor F·姆瓦勒J·安东尼奥L·哈格隆德P·J·拉夫利R·加夫里L·M·伊普M·P·格兰特
Owner MCGILL UNIV